LCI - Lannett launches two new products in U.S. January, 06 2020 07:10 AM Lannett Co Inc Lannett (NYSE:LCI) has commenced marketing Venlafaxine Extended Release (ER) Tablets, 150 mg and 225 mg, USP, and Lidocaine Topical Solution 4%.More news on: Lannett Company, Inc., Healthcare stocks news, Read more ...